Back to Search
DAVID STRAUS, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1285605998Individual
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
107110(NY)
Research & Publications (20)
Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma.
PMID 17366595·Cancer·2007
3-trial
Management of anemia in patients with hematologic malignancies.
PMID 16925104·Oncology (Williston Park)·2006
6-review
Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
PMID 16977654·Cancer·2006
4-observational
Treatment of anemia with erythropoietic agents in patients with hematologic malignancies.
PMID 18628176·Support Cancer Ther·2005
8-other
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.
PMID 15315964·Blood·2004
3-trial
Epoetin alfa therapy for patients with hematologic malignancies and mild anemia.
PMID 14556671·Clin Lymphoma·2003
3-trial
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma.
PMID 11785838·Recent Results Cancer Res·2002
3-trial
Epoetin alfa as a supportive measure in hematologic malignancies.
PMID 12447849·Semin Hematol·2002
6-review
Evaluation of potassium permanganate against an experimental subacute infection of Flavobacterium columnare in channel catfish, Ictalurus punctatus (Rafinesque).
PMID 19261046·J Fish Dis·2009
7-preclinical
Mycotoxin detection in human samples from patients exposed to environmental molds.
PMID 19468319·Int J Mol Sci·2009
8-other
Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre Phase 2 clinical trial.
PMID 19220284·Br J Haematol·2009
3-trial
Acute toxicity of peracetic acid (PAA) formulations to Ichthyophthirius multifiliis theronts.
PMID 19221794·Parasitol Res·2009
7-preclinical
Copper sulfate toxicity to two isolates of Ichthyophthirius multifiliis relative to alkalinity.
PMID 19301634·Dis Aquat Organ·2009
7-preclinical
Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion.
PMID 19443733·Am J Physiol Gastrointest Liver Physiol·2009
7-preclinical
Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma.
PMID 19624539·Br J Haematol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1285605998
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile